Article

ASCRS 2020: Assessing effectiveness of intracameral phenylephrine/ketorolac post-cataract surgery

Author(s):

Alex Delaney-Gesing
Conferences|ASCRS

Denise Visco, MD, speaks with Ophthalmology Times Executive Editor David Hutton on the findings from her poster on the effects of intracameral phenylephrine/ketorolac 1.0%/0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia following cataract surgery, during the 2020 ASCRS virtual meeting.

 

See more ASCRS coverage content here

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
Related Content
PainReform acquires majority equity interest in LayerBio
August 14th 2025

PainReform acquires majority equity interest in LayerBio

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
August 14th 2025

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

(Image credit: AdobeStock/zabhie) AI applications in cataract surgery: A surgeon’s perspective
August 14th 2025

AI applications in cataract surgery: A surgeon’s perspective

EyePod: Transforming the MIGS pipeline into clinical practice
August 14th 2025

EyePod: Transforming the MIGS pipeline into clinical reality

Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%
August 14th 2025

Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%

(Image credit: Wilmer Eye Institute/Johns Hopkins Medicine)
August 14th 2025

Wilmer Eye Institute marks 100 years: honoring the past, shaping the future

© 2025 MJH Life Sciences

All rights reserved.